Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Payables (2018 - 2025)

TransMedics (TMDX) has 8 years of Payables data on record, last reported at $10.4 million in Q4 2025.

  • For Q4 2025, Payables rose 0.56% year-over-year to $10.4 million; the TTM value through Dec 2025 reached $10.4 million, up 0.56%, while the annual FY2025 figure was $10.4 million, 0.56% up from the prior year.
  • Payables reached $10.4 million in Q4 2025 per TMDX's latest filing, down from $12.2 million in the prior quarter.
  • Across five years, Payables topped out at $13.1 million in Q3 2024 and bottomed at $1.3 million in Q1 2021.
  • Average Payables over 5 years is $7.7 million, with a median of $8.1 million recorded in 2023.
  • The widest YoY moves for Payables: up 451.49% in 2021, down 73.48% in 2021.
  • A 5-year view of Payables shows it stood at $6.7 million in 2021, then plummeted by 49.77% to $3.3 million in 2022, then soared by 280.63% to $12.7 million in 2023, then dropped by 19.07% to $10.3 million in 2024, then grew by 0.56% to $10.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $10.4 million in Q4 2025, $12.2 million in Q3 2025, and $9.5 million in Q2 2025.